Visitor Monitoring Drug History: EFFEXOR XR
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: EFFEXOR XR
FDA Application No: (NDA) 020699
Active Ingredient(s): VENLAFAXINE HYDROCHLORIDE
Company: WYETH PHARMS INC
 
Label History
 
View the label approved on September 26, 2007 for EFFEXOR XR, (NDA) 020699


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
9/20/2007 079Labeling Revision Letter
Label 
9/20/2007 077Labeling Revision Letter
Label 
8/1/2007 075Labeling Revision Letter
Label 
10/20/2006 072Labeling Revision Letter
Label 
9/14/2006 071Labeling Revision Letter
Label 
2/7/2007 069Labeling Revision Letter
Label 
3/2/2006 066Package Change Letter 
1/12/2006 064Labeling Revision Letter 
1/12/2006 062Labeling Revision Letter 
11/29/2005 059Patient Population Altered Letter
Label 
2/18/2005 058Labeling Revision Letter 
11/18/2005 057New or Modified Indication Letter
Label 
2/24/2006 056Labeling Revision Letter 
8/1/2007 055Labeling Revision Label 
11/18/2005 054New or Modified Indication Letter
Label 
5/13/2004 052Labeling Revision Letter
Label 
3/19/2004 050Labeling Revision Letter 
5/13/2004 048Labeling Revision Letter
Label 
4/8/2004 046Labeling Revision Letter 
3/16/2004 045Labeling Revision Letter 
9/2/2003 043Labeling Revision Letter
Review 
5/13/2004 041Labeling Revision Letter
Label 
3/19/2004 039Labeling Revision Letter 
9/2/2003 038Labeling Revision Letter
Review 
1/31/2003 034Supplement Review 
2/26/2003 032Labeling Revision Letter
Review 
5/5/2004 030Patient Population Altered Letter 
10/22/2002 029Labeling Revision Letter
Review 
11/19/2002 028Control Supplement  
1/31/2003 027Supplement Review 
1/31/2003 026Supplement Review 
8/7/2002 025Manufacturing Change or Addition  
10/23/2001 024Control Supplement  
1/31/2003 023Supplement Review 
2/11/2003 022New or Modified Indication Letter
Label 
1/31/2003 021Supplement Review 
12/13/2000 019Package Change  
1/31/2003 018Supplement Review 
10/31/2000 017Manufacturing Change or Addition  
5/2/2001 016New or Modified Indication Letter
Label
Review 
5/2/2001 015New or Modified Indication Letter
Label
Review 
1/31/2003 014Supplement Review 
7/20/2000 013Manufacturing Change or Addition  
6/12/2000 012Labeling Revision  
2/25/2000 011Manufacturing Change or Addition  
3/9/2000 010Manufacturing Change or Addition Review 
3/9/2000 009Manufacturing Change or Addition  
3/3/2000 008Labeling Revision  
7/13/2000 007Efficacy Supplement with Clinical Data to Support  
12/21/1999 006Manufacturing Change or Addition  
8/22/2001 005Manufacturing Change or Addition  
5/8/1998 002Manufacturing Change or Addition  
3/11/1999 001New or Modified Indication Letter
Label 
10/20/1997 000Approval Other Important Information from FDA 
 
There are no Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test